Treatment may not be necessary unless they cause pain. These calcifications are common, particularly in the pelvis. They are not usually a cause for concern and are rarely painful. However ...

The European Medicines Agency’s (EMA) human medicines committee has recommended Krystal Biotech’s Vyjuvek (beremagene geperpavec) to treat patients with the ultra-rare genetic blistering disease ...

for the treatment of wounds in patients with dystrophic epidermolysis bullosa (DEB) who have mutations in the collagen type VII alpha 1 chain (COL7A1) gene, starting from birth. The CHMP’s positive ...

or B-VEC), a topical gene therapy for treating wounds in patients with dystrophic epidermolysis bullosa (DEB) who have specific genetic mutations. The recommendation allows for administration in ...

So, there is a reasonable theory as to why K2 might reduce the risk of calcification of the blood vessels, which is highly (but not perfectly) associated with blockages in the arteries to the heart.

This valuable study reports the link between a disruption in testicular mineral (phosphate) homeostasis, FGF23 expression, and Sertoli cell dysfunction. The data supporting the conclusion are solid.

The concave zone of papillary calculi can contain a range of calcified lesions, from little HAP residues to typical well-developed HAP plaques, also known as Randall's plaques. The morphology of ...

Two of the difficulties associated with the biocompatibility of bioprosthetic valves are the possibilities of immune responses and calcification, which have led to either catastrophic failure or slow ...